Usefulness of field potential as a marker of embryonic stem cell-derived cardiomyocytes, and endpoint analysis of embryonic stem cell test

Journal of Toxicological Sciences

Volumn 35, Issue 6, 2010, Pages 899-909

  Koseki, Naoteru ^a   Deguchi, Jiro ^a   Yamada, Toru ^a   Funabashi, Hitoshi ^a   Seki, Takaki ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

Cardiac troponin T; Cardiomyocyte; Differentiation; Embryonic stem cell test (EST); Field potential

Indexed keywords

FLUOROURACIL; TROPONIN T;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRIC POTENTIAL; EMBRYONIC STEM CELL; EMBRYONIC STEM CELL TEST; HEART MUSCLE CELL; MICROELECTRODE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 78649837962     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.899     Document Type: Article

References (17)

1. Baharvand, H., Azarnia, M., Parivar, K. and Ashtiani, S.K. (2005): The effect of extracellular matrix on embryonic stem cell-derived cardiomyocytes. J. Mol. Cell Cardiol., 38, 495-503.
2. Baharvand, H., Piryaei, A., Rohani, R., Taei, A., Heidari, M.H. and Hosseini, A. (2006): Ultrastructural comparison of developing mouse embryonic stem cell- and in vivo-derived cardiomyocytes. Cell Biol. Int., 30, 800-807.
3. Banach, K., Halbach, M.D., Hu, P., Hescheler, J. and Egert, U. (2003): Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am. J. Physiol. Heart Cric. Physiol., 284, 2114-2123.
4. Boheler, K.R., Czyz, J., Tweedie, D., Yang, H.T., Anisimov, S.V. and Wobus, A.M. (2002): Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res., 91, 189-201.
5. Bremer, S., Worth, A.P., Paparella, M., Bigot, K., Kolossov, E., Fleischmann, B.K., Hescheler, J. and Balls, M. (2001): Establishment of an in vitro reporter gene assay for developmental cardiac toxicity. Toxicol. In Vitro, 15, 215-223.
6. Buesen, R., Genschow, E., Slawik, B., Visan, A., Spielmann, H., Luch, A. and Seiler, A. (2009): Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro. Toxicol. Sci., 108, 389-400.
7. Genschow, E., Spielmann, H., Scholz, G., Pohl, I., Seiler, A., Clemann, N., Bremer, S. and Becker, K. (2004): Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Aletern. Lab. Anim., 32, 209-244.
8. Guan, K., Fürst, D.O. and Wobus, A.M. (1999): Modulation of sarcomere organization during embryonic stem cell-derived cardiomyocyte differentiation. Eur. J. Cell Biol., 78, 813-823.
9. Ikeda, U. (2005): Biochemical markers for ischemic cardiac disease. In Kanai's Manual of Clinical Laboratory Medicine, Revised 32nd Edition (Kanai, M. and Okumura, N., eds.), pp.643-645, Kanehara & Company, Limited, Tokyo.
10. Koseki, N., Deguchi, J., Yamada, T., Funabashi, H. and Seki, T. (2010): Improvement of the embryonic stem cell test endpoint analysis by use of field potential detection. J. Toxicol. Sci., 35, 619-629.
11. McLean, M.J., Pelleg, A. and Sperelakis, N. (1979): Electrophysiological recordings from spontaneously contracting reaggregates of cultured smooth muscle cells from guinea pig vas deferens. J. Cell Biol., 80, 539-552.
12. Obinata, T. (1987): Skeletal muscle cell. In Isoration of functional cells and culture (Mitui, Y., Takagi, R., Ichihara, A., Sekiguchi, M. and Matumura, T., eds.), pp.349-355, Maruzen Company, Limited, Tokyo.
13. Ohnishi, Y., Kawakita, Y., Yamasaki, K., Fujisato, T. and Uto, S. (2008): Change of cell membrane potential with differentiation of myoblast. Seitaiikougaku, 46, 64-68.
14. Ozawa, E., Saito, K. and Hagiwara, Y. (1985): Skeletal muscle. In Advanced tissue cultures for in vitro assay and production (Yamane, I. and Endo, H., eds.), pp.41-54, Soft Science, Inc., Tokyo.
15. Peters, A.K., Wouwer, G.V., Weyn, B., Verheyen, G.R., Vanparys, P. and Gompel, J.V. (2008): Automated analysis of contractility in the embryonic stem cell test, a novel approach to assess embryotoxicity. Toxicol. In Vitro, 22, 1948-1956.
16. Seiler, A., Visan, A., Buesen, R., Genschow, E. and Spielmann, H. (2004): Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test. Reprod. Toxicol., 18, 231-240.
17. Westfall, M.V., Samuelson, L.C. and Metzger, J.M. (1996): Troponin I isoform expression is developmentally regulated in differentiating embryonic stem cell-derived cardiac myocytes. Dev. Dyn., 206, 24-38.